Cases & Deals

Conatus develops patent portfolio relating to small molecule liver disease drugs

Clients Conatus Pharmaceuticals, Inc.

Jones Day represents Conatus Pharmaceuticals, Inc. in establishing its patent portfolio for small molecule drugs relating to the treatment of liver disease.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.